Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
A limited number of congenital malformations of the respiratory tract can be identified directly by prenatal sonography.
These malformations should be described systematically because definitive diagnosis requires histologic examination.
The identification of subtle lesions that have no detrimental effect on a fetus or postnatal respiratory function is increasingly common.
A lack of evidence surrounding the natural history of asymptomatic cystic lung lesions has resulted in highly divergent postnatal management strategies.
A conservative approach to postnatal management of asymptomatic cases is a reasonable option.
Careful prenatal counselling is recommended.
Embryologic development of the respiratory tract requires the appropriate growth of the upper airway and the six ‘trees’ that make up the lower respiratory tract – bronchial, arterial (systemic and pulmonary), venous (systemic and pulmonary) and lymphatic – together with a normal thoracic volume, a normal thoracic skeletal structure and normal neuromuscular function.
Defects in any of these elements (except the systemic venous system because there are none known) can affect anatomical organisation resulting in a variety of congenital abnormalities. Whereas some lesions can be detected by direct prenatal sonographic visualisation, other lesions are suspected because of the presence of nonspecific findings (e.g., mediastinal shift) or form part of a more generalised genetic syndrome, for example, the pulmonary hypoplasia seen in skeletal dysplasias such asphyxiating thoracic dystrophy. Other congenital malformations of the lungs only become apparent in the postnatal period when they cause symptoms.
Not all congenital malformations have a detrimental impact on a fetus or postnatal respiratory function. Advances in sonographic technology allow prenatal detection of subtle lesions which may have no immediate clinical impact. A lack of evidence surrounding the natural history of asymptomatic cystic lung lesions has resulted in divergent postnatal management strategies and difficult prenatal counseling.
In this chapter, we will identify thoracic malformations, excluding congenital diaphragmatic hernia (covered in Chapter 31 ), that can be detected directly on prenatal sonography, describe a system to classify these lesions sonographically, define their salient pathological features and discuss the merits of prenatal and postnatal management options.
Thoracic malformations detectable on prenatal sonography are detailed in Table 30.1 ; however, a definitive diagnosis of these lesions (excluding congenital diaphragmatic hernia (CDH)) requires histologic confirmation. A prenatal or postnatal diagnosis is not possible by radiologic means alone. The imaging appearance of different types of lesions can be identical, rendering specific pathological diagnoses redundant and risking confusion in communication between medical professionals and families. Moreover, it is now apparent that there can be considerable overlap in histologic features within lesions, further highlighting the increasing complexity of diagnosis and the limitations of diagnosis based on imaging modalities alone.
Macrocystic Lesions |
Congenital pulmonary airway malformation |
Bronchogenic cyst or enteric cyst |
Congenital diaphragmatic hernia |
Bronchial atresia |
Congenital lobar emphysema |
Pleuropulmonary blastoma |
Microcystic Lesions |
Congenital pulmonary airway malformation |
Pulmonary sequestration |
Pleural effusion |
Tracheal or laryngeal atresia |
Pulmonary hypoplasia or agenesis |
Mediastinal teratoma |
Rhabdomyoma |
Ectopia |
In light of these difficulties, a system whereby malformations detected by prenatal sonography are described meticulously in simple language, based on their appearance, and without the presumption of a single pathological diagnosis has been recommended. Within this system, all thoracic malformations are described under the umbrella term congenital thoracic malformation (CTM). Malformations are then defined further using descriptive terms, including the presence and size of cysts, the presence of a feeding vessel, the degree of echogenicity, the presence or absence of mediastinal shift, polyhydramnios and the presence of anomalies in other systems. In practical terms, lesions have been most usefully classified sonographically as either macrocystic or microcystic (see Table 30.1 ).
Detection of CTMs, often at the routine 20-week anomaly scan, allows detailed planning of further prenatal management, including serial sonographic monitoring, delineation of the lesion and intrauterine therapeutic interventions if required. Planning for appropriate neonatal support on delivery can be prepared in advance. The exception to this pattern are pleural effusions, which often present later when scanning is undertaken because of a suspicion of increased amniotic fluid or as an incidental finding on ultrasound (USS) undertaken during the third trimester.
The appeal of enhanced prenatal radiologic definition of lung CTMs has led to the exploration of magnetic resonance imaging (MRI) as an additional modality. MRI has been used in the delineation of fetal lung lesions and the identification of feeding vessels, although this is readily done using Doppler ultrasound. Whether this enhanced imaging provides any additional information of practical value over ultrasound alone has yet to be determined, and in most centres at present, MRI is not part of routine practice.
Macrocytic lung lesions include congenital pulmonary airway malformations (CPAMs), bronchogenic cysts, enteric cysts, bronchial atresia and congenital lobar emphysema (see Table 30.1 ). The sonographic appearance includes a cystic lesion(s) of varying size in the thorax with or without mediastinal shift ( Fig. 30.1 ). An essential differential diagnosis to consider on identification of a macrocystic lung lesion is a left-sided diaphragmatic hernia, in which the stomach or bowel herniated into the thorax can be mistaken for a cystic structure. The crucial importance of this differentiation is the subsequent management strategy for CDH, particularly the place of delivery, associations with chromosomal abnormalities and genetic syndromes and general prognosis. Additional sonographic features that assist in the correct identification of a CDH include the absence of a stomach within the abdomen, the visualisation of peristalsis within the thorax, the paradoxical movement of abdominal viscera within the thorax during fetal breathing movements and absence of a diaphragm. However, differentiation can remain difficult on occasion. In a case series of 110 fetuses diagnosed with a CTM, two were later identified as having a diaphragmatic hernia, both after serial prenatal scanning.
Congenital pulmonary airway malformations were previously known as congenital cystic adenomatoid malformations (CCAM). In 2002, Stocker recommended the term CPAM as being preferable to the term congenital cystic adenomatoid malformation because not all types of CPAM are cystic and adenomatoid. The new terminology enables a better description of the entity’s alterations. For example, type 0 is not a cystic lesion, and types 0, 1 and 4 are not adenomatoid lesions.
Congenital pulmonary airway malformations represent the most common cystic lesions diagnosed on prenatal ultrasound. Currently, the best estimate of incidence reported by the European Surveillance of Congenital Anomalies (EUROCAT) is 0.94 in 10 000 live births. Although CPAMs can be defined as macrocystic or microcystic, both types are described in this section.
Opinions vary as to the aetiology of these lesions. Genetic abnormalities that may influence normal lung development or external insults disrupting lung growth have been postulated.
The subclassification of CPAM types remains contentious. Various systems of classification have been proposed with the most widely accepted that of Stocker. Within this system, CPAMs are classified into five types according to the level of the bronchial tree at which the defect is thought to have occurred. The strength of this classification is that specific neoplasms are associated with specific CPAM subgroups; however, these are not distinguishable with prenatal ultrasound, and postnatal histologic examination is required. There can be significant histologic overlap of lesions previously considered distinct (e.g., hybrid forms of CPAM, pulmonary sequestration (PS) and bronchial atresia).
This is a rare type of CPAM and is thought to develop at the level of the bronchus. On histologic examination, bronchial airways are present, but the distal parenchyma is highly unusual and consists mainly of mesenchymal tissue. Macroscopically, the lungs are small, and the condition is not compatible with life. The condition is also termed acinar dysplasia.
This is the most common type of CPAM, accounting for approximately 60% to 70% of cases. and thought to develop at the bronchial/bronchiolar level. The cysts range in diameter up to 10 cm, with at least one cyst more than 2 cm in diameter required for diagnosis. They are lined with pseudostratified ciliated columnar epithelium, with mucous cell proliferation also present on occasion.
These are less common than type 1 CPAMs, accounting for 15% to 20% of cases, and are thought to arise at the bronchiolar level. Lesions typically consist of multiple small cysts which range in size but must be less than 2 cm in diameter for diagnosis. The cysts are related to dilated bronchiole-like structures and are surrounded by simplified alveolar tissue. These lesions can be associated with other congenital abnormalities such as renal agenesis or dysplasia as well as cardiovascular and neurologic abnormalities.
These are a rare type of CPAM, accounting for 5% to 10% of cases thought to arise at the bronchiolar/alveolar duct level. Their inclusion as a CPAM is controversial because the microscopic features of excess bronchiolar ducts and parenchyma typical of fetal lung is considered by some pathologists to represent lung hyperplasia. The lesions can be large and affect an entire lobe with consequent compression of surrounding lung tissue.
These are very rare lesions and the most controversial of the CPAM diagnoses. The cysts can be large and are impossible to distinguish radiologically from type 1 CPAMs. On histologic examination, however, the cysts are lined with alveolar or bronchiolar epithelial cells upon mesenchymal tissue. The only difference between this lesion and a pleuropulmonary blastoma (PPB) is the absence of blastema. Some argue that these lesions in fact represent a regressed neoplasm rather than a form of CPAM.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here